0
0
11/16/23 at 8:21pm
Organization
Genetic Engineering & Biotechnology News
Author
Kathy Vuksanaj
49 words
0
Comments
In this GEN webinar, our speakers Lisa Caproni, PhD, from Touchlight and Pierre Marschall, PhD, from Odimma Therapeutics will discuss the application of Toughlight’s doggybone DNA (dbDNA™) in the development of a neoantigen for immune oncology.
You are the first to view
https://www.genengnews.com/multimedia/webinars/optimizing-personalized-cancer-immunotherapy-manufacturing-using-enzymatic-dna/
Create an account
or login to join the discussion